Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients.
Rocio, Carolina
Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients. [electronic resource] - Transactions of the Royal Society of Tropical Medicine and Hygiene Mar 2014 - 176-8 p. digital
Publication Type: Journal Article
1878-3503
10.1093/trstmh/tru011 doi
Adult
Aged
Aged, 80 and over
Amphotericin B--therapeutic use
Antiprotozoal Agents--therapeutic use
Dose-Response Relationship, Drug
Female
Humans
Leishmaniasis, Mucocutaneous--drug therapy
Male
Middle Aged
Retrospective Studies
Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients. [electronic resource] - Transactions of the Royal Society of Tropical Medicine and Hygiene Mar 2014 - 176-8 p. digital
Publication Type: Journal Article
1878-3503
10.1093/trstmh/tru011 doi
Adult
Aged
Aged, 80 and over
Amphotericin B--therapeutic use
Antiprotozoal Agents--therapeutic use
Dose-Response Relationship, Drug
Female
Humans
Leishmaniasis, Mucocutaneous--drug therapy
Male
Middle Aged
Retrospective Studies